Pharma CXO Roundtable
Exploring the Transformative Role of Generative AI in Drug Discovery and Personalized Medicine.
Register nowOverview
This roundtable delves into how Generative AI transforms drug discovery and personalized medicine in Pharma and Life Science. This session will focus on the Top Pharma Use Cases that could be solved by Generative AI which eventually speeds the growth, and revolutionizes the Pharmaceutical Organizations, from optimizing Drug Discovery to Drug Commercialization. Ethical and regulatory challenges will be addressed, aiming to foster collaboration for maximizing Generative AI's potential in healthcare innovation.
.webp)
Industry Recognition
Agilisium Recognized as a Leader in Everest Group Life Sciences Digital Services for Mid-Market Enterprises PEAK Matrix® Report.
The Everest Group evaluated Agilisium’s capabilities across the Life Sciences value chain along with client case studies and references.
Agilisium Recognized as a Product Challenger in ISG Provider Lens™ Life Sciences and Healthcare Analytics Services — Specialist Providers 2024 study.
The ISG Group evaluated Agilisium’s expertise in enabling enterprises to improve decision-making utilizing AI and analytics.
Agilisium Recognized as a Product Challenger in ISG Provider Lens™ AWS Ecosystem Partners — Data Analytics, AI and ML Providers 2023 study.
The ISG Group evaluated Agilisium’s ability to utilize analytics and ML to convert data into insights, driving innovation and efficiency in client operations.
